Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MKC +3.8%, UPS +3.2% (three-year outlook), ESLT +1.4%
Other news:
- STOK +94.6% (releases new data on STK-001)
- MESO +24.5% (FDA Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease)
- PRAX +18.8% (reports positive results of PRAX-628 study evaluating photo paroxysmal response, achieving 100% response in treated patients)
- VKTX +18% (announces results from phase 1 clinical trial of oral tablet formulation of dual GLP-1/GIP receptor agonist VK2735)
- DNUT +13.3% (McDonalds (MCD) and DNUT are teaming up for a national expansion)
- AMRX +5.8% (FDA approval for Ciprofloxacin and Dexamethasone Otic Suspension)
- APPF +5.6% (to replace NARI in S&P MidCap 400)
- PSTX +4.9% (appoints new CMO)
- NARI +2.9% (to replace CPE in S&P SmallCap 600)
- SKYW +2.5% (Board Chair retiring; names new Chair)
- EB +2.5% (CEO to also become Executive Chair)
- AG +2.4% (completed commissioning and commencement of bullion sales from its 100% owned and operated minting facility, First Mint)
- MAXN +1.9% (initiates patent infringement lawsuit against CSIQ)
- YOU +1.8% (entered into an agreement with Staples US Retail to offer its TSA PreCheck enrollment provided by CLEAR services at Staples retail stores across the country)
- DELL +1.7% (disclosed throughout FY24, it continued to take certain measures to reduce costs)
- BLUE +1.5% (files to delay its 10-K; Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance)
- PHYS +1.4% (discloses Royal Canadian Mint's Revised Fee Structure Notice)
- VSTO +1.3% (confirms unsolicitied $37.50/share interest from MNC Capital)
- VRCA +1.2% (announces that the Company's lead product, YCANTH, has received New Chemical Entity Status and a listing in the Orange Book from the U.S. FDA, providing a minimum five years of regulatory exclusivity)
- SVM +1% (Offer for OreCorp Lapsed)
- BTSG +1% (announces several recent tuck-in acquisitions within its service lines and geographies that continue to support market penetration and market density growth strategies)
Analyst comments:
- SPOT +2.5% (added to BofA's Best Ideas List)
- DKNG +1.2% (initiated with a Buy at Mizuho)
- NDAQ +1.1% (upgraded to Buy from Neutral at Goldman)
- MGM +1% (initiated with a Buy at Mizuho)
- LVS +0.7% (initiated with a Buy at Mizuho)